Loading...

James M Swanson

Title(s)Professor Emeritus, Pediatrics
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(949) 824-1824
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Examining Tolerance to CNS Stimulants in ADD
    NIH R01MH099030Apr 17, 2013 - Feb 29, 2020
    Role: Co-Principal Investigator
    Genetics of Attention Deficit-Hyperactivity Disorder
    NIH R01NS043740Sep 30, 2003 - May 31, 2008
    Role: Principal Investigator
    UCI-CFC Projects on School Readiness
    NIH R21MH068190Sep 25, 2002 - Aug 31, 2005
    Role: Principal Investigator
    Follow-up of the PATS Sample
    NIH U01MH060833Sep 22, 2000 - Nov 30, 2003
    Role: Co-Principal Investigator
    MULTIMODAL TREATMENT STUDY OF CHILDREN WITH ADHD (MTA)
    NIH U01MH050440Sep 30, 1992 - Sep 29, 1998
    Role: Principal Investigator
    EVALUATION OF WITHDRAWAL OF NEUROLEPTIC DRUGS IN THE DD
    NIH R01MH044844Aug 1, 1989 - Jul 31, 1992
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The World Federation of ADHD International Consensus Statement: 208 Evidence-based Conclusions about the Disorder. Neurosci Biobehav Rev. 2021 Feb 04. Faraone SV, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove MA, Newcorn JH, Gignac M, Al Saud NM, Manor I, Rohde LA, Yang L, Cortese S, Almagor D, Stein MA, Albatti TH, Aljoudi HF, Alqahtani MMJ, Asherson P, Atwoli L, Bölte S, Buitelaar JK, Crunelle CL, Daley D, Dalsgaard S, Döepfner M, Espinet S, Fitzgerald M, Franke B, Haavik J, Hartman CA, Hartung CM, Hinshaw SP, Hoekstra PJ, Hollis C, Kollins SH, Sandra Kooij JJ, Kuntsi J, Larsson H, Li T, Liu J, Merzon E, Mattingly G, Mattos P, McCarthy S, Mikami AY, Molina BSG, Nigg JT, Purper-Ouakil D, Omigbodun OO, Polanczyk GV, Pollak Y, Poulton AS, Rajkumar RP, Reding A, Reif A, Rubia K, Rucklidge J, Romanos M, Ramos-Quiroga JA, Schellekens A, Scheres A, Schoeman R, Schweitzer JB, Shah H, Solanto MV, Sonuga-Barke E, Soutullo C, Steinhausen HC, Swanson JM, Thapar A, Tripp G, van de Glind G, Brink WVD, Van der Oord S, Venter A, Vitiello B, Walitza S, Wang Y. PMID: 33549739.
      View in: PubMed   Mentions:    Fields:    
    2. Lessons From the 1918 Flu Pandemic: A Novel Etiologic Subtype of ADHD? J Am Acad Child Adolesc Psychiatry. 2021 01; 60(1):1-2. Swanson JM, Volkow ND. PMID: 33186710.
      View in: PubMed   Mentions:
    3. Early substance use in the pathway from childhood attention-deficit/hyperactivity disorder (ADHD) to young adult substance use: Evidence of statistical mediation and substance specificity. Psychol Addict Behav. 2020 Mar; 34(2):281-292. Howard AL, Kennedy TM, Mitchell JT, Sibley MH, Hinshaw SP, Arnold LE, Roy A, Stehli A, Swanson JM, Molina BSG. PMID: 31886682.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Depression and ADHD-Related Risk for Substance Use in Adolescence and Early Adulthood: Concurrent and Prospective Associations in the MTA. J Abnorm Child Psychol. 2019 12; 47(12):1903-1916. Howard AL, Kennedy TM, Macdonald EP, Mitchell JT, Sibley MH, Roy A, Arnold LE, Epstein JN, Hinshaw SP, Hoza B, Stehli A, Swanson JM, Molina BSG. PMID: 31273568.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long Term? (Against). J Am Acad Child Adolesc Psychiatry. 2019 10; 58(10):936-938. Swanson JM. PMID: 31515165.
      View in: PubMed   Mentions:
    6. A Randomized Controlled Trial of Interventions for Growth Suppression in Children With Attention-Deficit/Hyperactivity Disorder Treated With Central Nervous System Stimulants. J Am Acad Child Adolesc Psychiatry. 2020 Dec; 59(12):1330-1341. Waxmonsky JG, Pelham WE, Campa A, Waschbusch DA, Li T, Marshall R, Babocsai L, Humphery H, Gnagy E, Swanson J, Hanc T, Fallahazad N, Pelham WE. PMID: 31473291.
      View in: PubMed   Mentions:
    7. Effects of Childhood and Adult Persistent Attention-Deficit/Hyperactivity Disorder on Risk of Motor Vehicle Crashes: Results From the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2020 Aug; 59(8):952-963. Roy A, Garner AA, Epstein JN, Hoza B, Nichols JQ, Molina BSG, Swanson JM, Arnold LE, Hechtman L. PMID: 31445873.
      View in: PubMed   Mentions:
    8. Adult substance use as a function of growth in peer use across adolescence and young adulthood in the context of ADHD: Findings from the MTA. Addict Behav. 2019 12; 99:106106. Kennedy TM, Howard AL, Mitchell JT, Hoza B, Arnold LE, Hechtman LT, Swanson JM, Stehli A, Molina BSG. PMID: 31473568.
      View in: PubMed   Mentions:
    9. Measuring strengths and weaknesses in dimensional psychiatry. J Child Psychol Psychiatry. 2020 01; 61(1):40-50. Alexander LM, Salum GA, Swanson JM, Milham MP. PMID: 31423596.
      View in: PubMed   Mentions:
    10. Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2020 Aug; 59(8):978-989. Greenhill LL, Swanson JM, Hechtman L, Waxmonsky J, Arnold LE, Molina BSG, Hinshaw SP, Jensen PS, Abikoff HB, Wigal T, Stehli A, Howard A, Hermanussen M, Hanc T. PMID: 31421233.
      View in: PubMed   Mentions: 1     Fields:    
    11. A risk calculator to predict adult attention-deficit/hyperactivity disorder: generation and external validation in three birth cohorts and one clinical sample - ERRATUM. Epidemiol Psychiatr Sci. 2019 Jul 03; 1-2. Caye A, Agnew-Blais J, Arseneault L, Gonçalves H, Kieling C, Langley K, Menezes AMB, Moffitt TE, Passos IC, Rocha TB, Sibley MH, Swanson JM, Thapar A, Wehrmeister F, Rohde LA. PMID: 31267886.
      View in: PubMed   Mentions:
    12. A risk calculator to predict adult attention-deficit/hyperactivity disorder: generation and external validation in three birth cohorts and one clinical sample. Epidemiol Psychiatr Sci. 2019 May 15; 29:e37. Caye A, Agnew-Blais J, Arseneault L, Gonçalves H, Kieling C, Langley K, Menezes AMB, Moffitt TE, Passos IC, Rocha TB, Sibley MH, Swanson JM, Thapar A, Wehrmeister F, Rohde LA. PMID: 31088588.
      View in: PubMed   Mentions:
    13. Cigarette Smoking Progression Among Young Adults Diagnosed With ADHD in Childhood: A 16-year Longitudinal Study of Children With and Without ADHD. Nicotine Tob Res. 2019 04 17; 21(5):638-647. Mitchell JT, Howard AL, Belendiuk KA, Kennedy TM, Stehli A, Swanson JM, Hechtman L, Arnold LE, Hoza B, Vitiello B, Lu B, Kollins SH, Molina BSG. PMID: 29538764.
      View in: PubMed   Mentions:
    14. A Qualitative Analysis of Contextual Factors Relevant to Suspected Late-Onset ADHD. J Atten Disord. 2019 Apr 01; 1087054719837743. Mitchell JT, Sibley MH, Hinshaw SP, Kennedy TM, Chronis-Tuscano A, Arnold LE, Swanson JM, Hechtman LT, Molina BSG, Caye A, Tamm L, Owens EB, Roy A, Weisner TS, Murray DW, Jensen PS. PMID: 30929549.
      View in: PubMed   Mentions: 1     Fields:    
    15. Meeting Report: The Role of Beliefs and Perception on Body Size. Proceedings of the 26th Aschauer Soiree, Held at Aschauhof, Altenhof, Germany, May 26th, 2018. Pediatr Endocrinol Rev. 2019 Mar; 16(3):383-400. Hermanussen M, Pulungan AB, Scheffler C, Mumm R, Rogol AD, Pop R, Swanson JM, Sonuga-Barke E, Reimann A, Siniarska-Wolanska A, Musalek M, Bogin B, Boldsen JL, Tassenaar PGV, Groth D, Liu YC, Meigen C, Quanjer B, Thompson K, Özer BK, Bryl E, Mamrot P, Hanc T, Koziel S, Söderhäll J, Gomula A, Banik SD, Roelants M, Veldre G, Lieberman LS, Sievert LL. PMID: 30888128.
      View in: PubMed   Mentions:
    16. ADGRL3 (LPHN3) variants predict substance use disorder. Transl Psychiatry. 2019 01 29; 9(1):42. Arcos-Burgos M, Vélez JI, Martinez AF, Ribasés M, Ramos-Quiroga JA, Sánchez-Mora C, Richarte V, Roncero C, Cormand B, Fernández-Castillo N, Casas M, Lopera F, Pineda DA, Palacio JD, Acosta-López JE, Cervantes-Henriquez ML, Sánchez-Rojas MG, Puentes-Rozo PJ, Molina BSG, Boden MT, Wallis D, Lidbury B, Newman S, Easteal S, Swanson J, Patel H, Volkow N, Acosta MT, Castellanos FX, de Leon J, Mastronardi CA, Muenke M. PMID: 30696812.
      View in: PubMed   Mentions:
    17. Predictive utility of childhood diagnosis of ICD-10 hyperkinetic disorder: adult outcomes in the MTA and effect of comorbidity. Eur Child Adolesc Psychiatry. 2019 Apr; 28(4):557-570. Arnold LE, Roy A, Taylor E, Hechtman L, Sibley M, Swanson JM, Mitchell JT, Molina BSG, Rohde LA. PMID: 30232561.
      View in: PubMed   Mentions:
    18. Risk of Bias and Quality of Evidence for Treatment of ADHD With Stimulant Medication. Clin Pharmacol Ther. 2018 10; 104(4):638-643. Swanson JM. PMID: 30066372.
      View in: PubMed   Mentions:
    19. Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study. Eur J Neurosci. 2018 08; 48(3):1884-1895. Wiers CE, Lohoff FW, Lee J, Muench C, Freeman C, Zehra A, Marenco S, Lipska BK, Auluck PK, Feng N, Sun H, Goldman D, Swanson JM, Wang GJ, Volkow ND. PMID: 30033547.
      View in: PubMed   Mentions:
    20. The Importance of Scrutinizing Emergent ADHD Symptoms in Adults: Response to Chamberlain and Müller. Am J Psychiatry. 2018 05 01; 175(5):480-481. Sibley MH, Arnold LE, Swanson JM, Kennedy TM, Molina BSG, Hechtman LT, Roy A, Mitchell JT. PMID: 29712477.
      View in: PubMed   Mentions:
    21. Addressing Incomplete Psychiatric Histories in Adult ADHD: Response to Agnew-Blais and Arseneault. Am J Psychiatry. 2018 05 01; 175(5):482-483. Sibley MH, Arnold LE, Swanson JM, Kennedy TM, Molina BSG, Hechtman LT, Roy A, Mitchell JT. PMID: 29712471.
      View in: PubMed   Mentions:
    22. Substance use through adolescence into early adulthood after childhood-diagnosed ADHD: findings from the MTA longitudinal study. J Child Psychol Psychiatry. 2018 06; 59(6):692-702. Molina BSG, Howard AL, Swanson JM, Stehli A, Mitchell JT, Kennedy TM, Epstein JN, Arnold LE, Hechtman L, Vitiello B, Hoza B. PMID: 29315559.
      View in: PubMed   Mentions:
    23. The Qualitative Interview Study of Persistent and Nonpersistent Substance Use in the MTA: Sample Characteristics, Frequent Use, and Reasons for Use. J Atten Disord. 2018 07; 22(9_suppl):21S-37S. Swanson JM, Wigal T, Jensen PS, Mitchell JT, Weisner TS, Murray D, Arnold LE, Hechtman L, Molina BSG, Owens EB, Hinshaw SP, Belendiuk K, Howard A, Wigal SB, Sorensen P, Stehli A. PMID: 29090967.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25. Am J Psychiatry. 2018 02 01; 175(2):140-149. Sibley MH, Rohde LA, Swanson JM, Hechtman LT, Molina BSG, Mitchell JT, Arnold LE, Caye A, Kennedy TM, Roy A, Stehli A. PMID: 29050505.
      View in: PubMed   Mentions:
    25. Childhood ADHD and Involvement in Early Pregnancy: Mechanisms of Risk. J Atten Disord. 2020 Dec; 24(14):1955-1965. Meinzer MC, LeMoine KA, Howard AL, Stehli A, Arnold LE, Hechtman L, Hinshaw SP, Molina BSG, Murray DW, Sibley MH, Swanson JM, Tamm L, Chronis-Tuscano A. PMID: 28938857.
      View in: PubMed   Mentions: 1     Fields:    
    26. Follow-Up of Young Adults With ADHD in the MTA: Design and Methods for Qualitative Interviews. J Atten Disord. 2018 07; 22(9_suppl):10S-20S. Weisner TS, Murray DW, Jensen PS, Mitchell JT, Swanson JM, Hinshaw SP, Wells K, Hechtman L, Molina BSG, Arnold LE, Sorensen P, Stehli A. PMID: 28617075.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    27. Childhood Predictors of Adult Functional Outcomes in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder (MTA). J Am Acad Child Adolesc Psychiatry. 2017 Aug; 56(8):687-695.e7. Roy A, Hechtman L, Arnold LE, Swanson JM, Molina BSG, Sibley MH, Howard AL. PMID: 28735698.
      View in: PubMed   Mentions:
    28. Turning Points in the Lives of Youth of With/Without ADHD: Are They Linked to Changes in Substance Use? J Atten Disord. 2018 07; 22(9_suppl):38S-48S. Jensen PS, Yuki K, Murray D, Mitchell JT, Weisner T, Hinshaw S, Molina B, Swanson J, Arnold LE, Hechtman L, Wells K. PMID: 28423975.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Sequencing of sporadic Attention-Deficit Hyperactivity Disorder (ADHD) identifies novel and potentially pathogenic de novo variants and excludes overlap with genes associated with autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet. 2017 Jun; 174(4):381-389. Kim DS, Burt AA, Ranchalis JE, Wilmot B, Smith JD, Patterson KE, Coe BP, Li YK, Bamshad MJ, Nikolas M, Eichler EE, Swanson JM, Nigg JT, Nickerson DA, Jarvik GP. PMID: 28332277.
      View in: PubMed   Mentions:
    30. Family-based association study of DRD4 gene in methylphenidate-responded Attention Deficit/Hyperactivity Disorder. PLoS One. 2017; 12(3):e0173748. Leung PW, Chan JK, Chen LH, Lee CC, Hung SF, Ho TP, Tang CP, Moyzis RK, Swanson JM. PMID: 28282463.
      View in: PubMed   Mentions:
    31. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression. J Child Psychol Psychiatry. 2017 Jun; 58(6):663-678. Swanson JM, Arnold LE, Molina BSG, Sibley MH, Hechtman LT, Hinshaw SP, Abikoff HB, Stehli A, Owens EB, Mitchell JT, Nichols Q, Howard A, Greenhill LL, Hoza B, Newcorn JH, Jensen PS, Vitiello B, Wigal T, Epstein JN, Tamm L, Lakes KD, Waxmonsky J, Lerner M, Etcovitch J, Murray DW, Muenke M, Acosta MT, Arcos-Burgos M, Pelham WE, Kraemer HC. PMID: 28295312.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    32. How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning. J Atten Disord. 2018 07; 22(9_suppl):49S-60S. Mitchell JT, Weisner TS, Jensen PS, Murray DW, Molina BSG, Arnold LE, Hechtman L, Swanson JM, Hinshaw SP, Victor EC, Kollins SH, Wells KC, Belendiuk KA, Blonde A, Nguyen C, Ambriz L, Nguyen JL. PMID: 28166690.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    33. Life Span Studies of ADHD-Conceptual Challenges and Predictors of Persistence and Outcome. Curr Psychiatry Rep. 2016 Dec; 18(12):111. Caye A, Swanson J, Thapar A, Sibley M, Arseneault L, Hechtman L, Arnold LE, Niclasen J, Moffitt T, Rohde LA. PMID: 27783340.
      View in: PubMed   Mentions:
    34. Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity. J Child Psychol Psychiatry. 2017 Jun; 58(6):655-662. Sibley MH, Swanson JM, Arnold LE, Hechtman LT, Owens EB, Stehli A, Abikoff H, Hinshaw SP, Molina BSG, Mitchell JT, Jensen PS, Howard AL, Lakes KD, Pelham WE, . PMID: 27642116.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    35. Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults. Neuroimage Clin. 2017; 13:188-200. Kelly C, Castellanos FX, Tomaselli O, Lisdahl K, Tamm L, Jernigan T, Newman E, Epstein JN, Molina BS, Greenhill LL, Potkin SG, Hinshaw S, Swanson JM, . PMID: 27995073.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    36. Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults. Neuroimage Clin. 2017; 13:188-200. Kelly C, Castellanos FX, Tomaselli O, Lisdahl K, Tamm L, Jernigan T, Newman E, Epstein JN, Molina BSG, Greenhill LL, Potkin SG, Hinshaw S, Swanson JM. PMID: 30240350.
      View in: PubMed   Mentions: 1     Fields:    
    37. Childhood Factors Affecting Persistence and Desistence of Attention-Deficit/Hyperactivity Disorder Symptoms in Adulthood: Results From the MTA. J Am Acad Child Adolesc Psychiatry. 2016 11; 55(11):937-944.e4. Roy A, Hechtman L, Arnold LE, Sibley MH, Molina BS, Swanson JM, Howard AL. PMID: 27806861.
      View in: PubMed   Mentions:
    38. Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results. J Am Acad Child Adolesc Psychiatry. 2016 11; 55(11):945-952.e2. Hechtman L, Swanson JM, Sibley MH, Stehli A, Owens EB, Mitchell JT, Arnold LE, Molina BS, Hinshaw SP, Jensen PS, Abikoff HB, Perez Algorta G, Howard AL, Hoza B, Etcovitch J, Houssais S, Lakes KD, Nichols JQ, . PMID: 27806862.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    39. ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task. Brain Imaging Behav. 2016 09; 10(3):761-71. Rasmussen J, Casey BJ, van Erp TG, Tamm L, Epstein JN, Buss C, Bjork JM, Molina BS, Velanova K, Mathalon DH, Somerville L, Swanson JM, Wigal T, Arnold LE, Potkin SG, . PMID: 26489976.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    40. Go/No Go task performance predicts cortical thickness in the caudal inferior frontal gyrus in young adults with and without ADHD. Brain Imaging Behav. 2016 09; 10(3):880-92. Newman E, Jernigan TL, Lisdahl KM, Tamm L, Tapert SF, Potkin SG, Mathalon D, Molina B, Bjork J, Castellanos FX, Swanson J, Kuperman JM, Bartsch H, Chen CH, Dale AM, Epstein JN, . PMID: 26404018.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    41. ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study. Mol Genet Genomic Med. 2016 Sep; 4(5):540-7. Acosta MT, Swanson J, Stehli A, Molina BS, Martinez AF, Arcos-Burgos M, Muenke M. PMID: 27652281.
      View in: PubMed   Mentions:
    42. Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome. JAMA Psychiatry. 2016 07 01; 73(7):705-12. Caye A, Rocha TB, Anselmi L, Murray J, Menezes AM, Barros FC, Gonçalves H, Wehrmeister F, Jensen CM, Steinhausen HC, Swanson JM, Kieling C, Rohde LA. PMID: 27192050.
      View in: PubMed   Mentions:
    43. ADHD in context: Young adults' reports of the impact of occupational environment on the manifestation of ADHD. Soc Sci Med. 2016 07; 161:160-8. Lasky AK, Weisner TS, Jensen PS, Hinshaw SP, Hechtman L, Arnold LE, W Murray D, Swanson JM. PMID: 27299978.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review. JAMA Psychiatry. 2016 Mar; 73(3):292-7. Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, Bloomfield MA, Curran HV, Baler R. PMID: 26842658.
      View in: PubMed   Mentions:
    45. The impact of ADHD persistence, recent cannabis use, and age of regular cannabis use onset on subcortical volume and cortical thickness in young adults. Drug Alcohol Depend. 2016 Apr 01; 161:135-46. Lisdahl KM, Tamm L, Epstein JN, Jernigan T, Molina BS, Hinshaw SP, Swanson JM, Newman E, Kelly C, Bjork JM, . PMID: 26897585.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    46. Progression of impairment in adolescents with attention-deficit/hyperactivity disorder through the transition out of high school: Contributions of parent involvement and college attendance. J Abnorm Psychol. 2016 Feb; 125(2):233-247. Howard AL, Strickland NJ, Murray DW, Tamm L, Swanson JM, Hinshaw SP, Arnold LE, Molina BSG. PMID: 26854508.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    47. Risk for emerging bipolar disorder, variants, and symptoms in children with attention deficit hyperactivity disorder, now grown up. World J Psychiatry. 2015 Dec 22; 5(4):412-24. Elmaadawi AZ, Jensen PS, Arnold LE, Molina BS, Hechtman L, Abikoff HB, Hinshaw SP, Newcorn JH, Greenhill LL, Swanson JM, Galanter CA. PMID: 26740933.
      View in: PubMed   Mentions:
    48. ADHD Prevalence: Altitude or Sunlight? Better Understanding the Interrelations of Dopamine and the Circadian System. J Atten Disord. 2018 01; 22(2):163-166. Arns M, Swanson JM, Arnold LE. PMID: 26341278.
      View in: PubMed   Mentions:
    49. Developmental progression to early adult binge drinking and marijuana use from worsening versus stable trajectories of adolescent attention deficit/hyperactivity disorder and delinquency. Addiction. 2015 May; 110(5):784-95. Howard AL, Molina BS, Swanson JM, Hinshaw SP, Belendiuk KA, Harty SC, Arnold LE, Abikoff HB, Hechtman L, Stehli A, Greenhill LL, Newcorn JH, Wigal T. PMID: 25664657.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    50. A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior. Pharmacol Biochem Behav. 2015 Apr; 131:143-53. Thanos PK, Robison LS, Steier J, Hwang YF, Cooper T, Swanson JM, Komatsu DE, Hadjiargyrou M, Volkow ND. PMID: 25641666.
      View in: PubMed   Mentions:
    51. Maternal ADHD Symptoms, Personality, and Parenting Stress: Differences Between Mothers of Children With ADHD and Mothers of Comparison Children. J Atten Disord. 2018 11; 22(13):1266-1277. Perez Algorta G, Kragh CA, Arnold LE, Molina BSG, Hinshaw SP, Swanson JM, Hechtman L, Copley LM, Lowe M, Jensen PS. PMID: 25525155.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    52. Prevalence and Characteristics of School Services for High School Students with Attention-Deficit/Hyperactivity Disorder. School Ment Health. 2014 Dec 01; 6(4):264-278. Murray DW, Molina BS, Glew K, Houck P, Greiner A, Fong D, Swanson J, Arnold LE, Lerner M, Hechtman L, Abikoff HB, Jensen PS. PMID: 25506403.
      View in: PubMed   Mentions:
    53. Increased brain activity to unpleasant stimuli in individuals with the 7R allele of the DRD4 gene. Psychiatry Res. 2015 Jan 30; 231(1):58-63. Gehricke JG, Swanson JM, Duong S, Nguyen J, Wigal TL, Fallon J, Caburian C, Muftuler LT, Moyzis RK. PMID: 25481571.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    54. Social Self Control, Externalizing Behavior, and Peer Liking Among Children with ADHD-CT: A Mediation Model. Soc Dev. 2014 May 01; 23(2):288-305. Rosen PJ, Vaughn AJ, Epstein JN, Hoza B, Arnold LE, Hechtman L, Molina BS, Swanson JM. PMID: 25346578.
      View in: PubMed   Mentions:
    55. Community member and faith leader perspectives on the process of building trusting relationships between communities and researchers. Clin Transl Sci. 2014 Feb; 7(1):20-8. Lakes KD, Vaughan E, Pham J, Tran T, Jones M, Baker D, Swanson JM, Olshansky E. PMID: 24405695.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    56. Clinical practice: Adult attention deficit-hyperactivity disorder. N Engl J Med. 2013 Nov 14; 369(20):1935-44. Volkow ND, Swanson JM. PMID: 24224626.
      View in: PubMed   Mentions:
    57. Brown adipose tissue quantification in human neonates using water-fat separated MRI. PLoS One. 2013; 8(10):e77907. Rasmussen JM, Entringer S, Nguyen A, van Erp TG, Burns J, Guijarro A, Oveisi F, Swanson JM, Piomelli D, Wadhwa PD, Buss C, Potkin SG. PMID: 24205024.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    58. Reply to: Attention-deficit/hyperactivity disorder and solar irradiance: a cloudy perspective. Biol Psychiatry. 2014 Oct 15; 76(8):e21-3. Arns M, van der Heijden KB, Arnold LE, Swanson JM, Kenemans JL. PMID: 24252358.
      View in: PubMed   Mentions:
    59. Psychometric properties of Japanese version of the Swanson, Nolan, and Pelham, version-IV Scale-Teacher Form: a study of school children in community samples. Brain Dev. 2014 Sep; 36(8):700-6. Inoue Y, Ito K, Kita Y, Inagaki M, Kaga M, Swanson JM. PMID: 24075708.
      View in: PubMed   Mentions:
    60. Impact of ADHD and cannabis use on executive functioning in young adults. Drug Alcohol Depend. 2013 Dec 01; 133(2):607-14. Tamm L, Epstein JN, Lisdahl KM, Molina B, Tapert S, Hinshaw SP, Arnold LE, Velanova K, Abikoff H, Swanson JM, . PMID: 23992650.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    61. Does childhood positive self-perceptual bias mediate adolescent risky behavior in youth from the MTA study? J Consult Clin Psychol. 2013 Oct; 81(5):846-58. Hoza B, McQuade JD, Murray-Close D, Shoulberg E, Molina BS, Arnold LE, Swanson J, Hechtman L. PMID: 23834228.
      View in: PubMed   Mentions:
    62. Association between dopamine D4 receptor polymorphism and age related changes in brain glucose metabolism. PLoS One. 2013; 8(5):e63492. Volkow ND, Tomasi D, Wang GJ, Telang F, Fowler JS, Goldstein RZ, Klein N, Wong C, Swanson JM, Shumay E. PMID: 23717434.
      View in: PubMed   Mentions:
    63. Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder. PLoS One. 2013; 8(5):e63023. Wang GJ, Volkow ND, Wigal T, Kollins SH, Newcorn JH, Telang F, Logan J, Jayne M, Wong CT, Han H, Fowler JS, Zhu W, Swanson JM. PMID: 23696790.
      View in: PubMed   Mentions:
    64. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry. 2013 Mar; 52(3):250-63. Molina BS, Hinshaw SP, Eugene Arnold L, Swanson JM, Pelham WE, Hechtman L, Hoza B, Epstein JN, Wigal T, Abikoff HB, Greenhill LL, Jensen PS, Wells KC, Vitiello B, Gibbons RD, Howard A, Houck PR, Hur K, Lu B, Marcus S. PMID: 23452682.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    65. Maternal perspectives on the return of genetic results: context matters. . 2013 Jan; 161A(1):38-47. Lakes KD, Vaughan E, Lemke A, Jones M, Wigal T, Baker D, Swanson JM, Burke W. PMID: 23239553.
      View in: PubMed   Mentions:
    66. Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates. Neuropsychopharmacology. 2012 Nov; 37(12):2555-65. Gill KE, Pierre PJ, Daunais J, Bennett AJ, Martelle S, Gage HD, Swanson JM, Nader MA, Porrino LJ. PMID: 22805600.
      View in: PubMed   Mentions:
    67. Pooling/bootstrap-based GWAS (pbGWAS) identifies new loci modifying the age of onset in PSEN1 p.Glu280Ala Alzheimer's disease. Mol Psychiatry. 2013 May; 18(5):568-75. Vélez JI, Chandrasekharappa SC, Henao E, Martinez AF, Harper U, Jones M, Solomon BD, Lopez L, Garcia G, Aguirre-Acevedo DC, Acosta-Baena N, Correa JC, Lopera-Gómez CM, Jaramillo-Elorza MC, Rivera D, Kosik KS, Schork NJ, Swanson JM, Lopera F, Arcos-Burgos M. PMID: 22710270.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    68. Impaired executive function mediates the association between maternal pre-pregnancy body mass index and child ADHD symptoms. PLoS One. 2012; 7(6):e37758. Buss C, Entringer S, Davis EP, Hobel CJ, Swanson JM, Wadhwa PD, Sandman CA. PMID: 22719848.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    69. Fetal programming of body composition, obesity, and metabolic function: the role of intrauterine stress and stress biology. J Nutr Metab. 2012; 2012:632548. Entringer S, Buss C, Swanson JM, Cooper DM, Wing DA, Waffarn F, Wadhwa PD. PMID: 22655178.
      View in: PubMed   Mentions:
    70. The Role of Stress in Brain Development: The Gestational Environment's Long-Term Effects on the Brain. Cerebrum. 2012 Mar; 2012:4. Buss C, Entringer S, Swanson JM, Wadhwa PD. PMID: 23447790.
      View in: PubMed   Mentions:
    71. Categorical and Dimensional Definitions and Evaluations of Symptoms of ADHD: History of the SNAP and the SWAN Rating Scales. Int J Educ Psychol Assess. 2012 Apr; 10(1):51-70. Swanson JM, Schuck S, Porter MM, Carlson C, Hartman CA, Sergeant JA, Clevenger W, Wasdell M, McCleary R, Lakes K, Wigal T. PMID: 26504617.
      View in: PubMed   Mentions:
    72. Chronic exposure to methylphenidate impairs appendicular bone quality in young rats. Bone. 2012 Jun; 50(6):1214-22. Komatsu DE, Thanos PK, Mary MN, Janda HA, John CM, Robison L, Ananth M, Swanson JM, Volkow ND, Hadjiargyrou M. PMID: 22465849.
      View in: PubMed   Mentions:
    73. Diverse perceptions of the informed consent process: implications for the recruitment and participation of diverse communities in the National Children's Study. Am J Community Psychol. 2012 Mar; 49(1-2):215-32. Lakes KD, Vaughan E, Jones M, Burke W, Baker D, Swanson JM. PMID: 21671109.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    74. Time-of-day effects in arousal: disrupted diurnal cortisol profiles in children with ADHD. J Child Psychol Psychiatry. 2012 Jul; 53(7):782-9. Imeraj L, Antrop I, Roeyers H, Swanson J, Deschepper E, Bal S, Deboutte D. PMID: 22324289.
      View in: PubMed   Mentions:
    75. Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. Am J Psychiatry. 2012 Feb; 169(2):167-77. Vitiello B, Elliott GR, Swanson JM, Arnold LE, Hechtman L, Abikoff H, Molina BS, Wells K, Wigal T, Jensen PS, Greenhill LL, Kaltman JR, Severe JB, Odbert C, Hur K, Gibbons R. PMID: 21890793.
      View in: PubMed   Mentions:
    76. Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. J Neurosci. 2012 Jan 18; 32(3):841-9. Volkow ND, Wang GJ, Tomasi D, Kollins SH, Wigal TL, Newcorn JH, Telang FW, Fowler JS, Logan J, Wong CT, Swanson JM. PMID: 22262882.
      View in: PubMed   Mentions:
    77. Contrast of medical and nonmedical use of stimulant drugs, basis for the distinction, and risk of addiction: comment on Smith and Farah (2011). Psychol Bull. 2011 Sep; 137(5):742-8. Swanson JM, Wigal TL, Volkow ND. PMID: 21859175.
      View in: PubMed   Mentions:
    78. Relation between outcomes on a continuous performance test and ADHD symptoms over time. J Abnorm Child Psychol. 2011 Aug; 39(6):853-64. Vaughn AJ, Epstein JN, Rausch J, Altaye M, Langberg J, Newcorn JH, Hinshaw SP, Hechtman L, Arnold LE, Swanson JM, Wigal T. PMID: 21476025.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    79. The reliability and validity of the English and Spanish Strengths and Weaknesses of ADHD and Normal behavior rating scales in a preschool sample: continuum measures of hyperactivity and inattention. J Atten Disord. 2012 Aug; 16(6):510-6. Lakes KD, Swanson JM, Riggs M. PMID: 21807955.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    80. Patterns and predictors of adolescent academic achievement and performance in a sample of children with attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol. 2011; 40(4):519-31. Langberg JM, Molina BS, Arnold LE, Epstein JN, Altaye M, Hinshaw SP, Swanson JM, Wigal T, Hechtman L. PMID: 21722025.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    81. Developmental processes in peer problems of children with attention-deficit/hyperactivity disorder in the Multimodal Treatment Study of Children With ADHD: developmental cascades and vicious cycles. Dev Psychopathol. 2010 Nov; 22(4):785-802. Murray-Close D, Hoza B, Hinshaw SP, Arnold LE, Swanson J, Jensen PS, Hechtman L, Wells K. PMID: 20883582.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    82. Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology. 2011 Jan; 36(1):207-26. Swanson J, Baler RD, Volkow ND. PMID: 20881946.
      View in: PubMed   Mentions:
    83. Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Mol Psychiatry. 2011 Nov; 16(11):1147-54. Volkow ND, Wang GJ, Newcorn JH, Kollins SH, Wigal TL, Telang F, Fowler JS, Goldstein RZ, Klein N, Logan J, Wong C, Swanson JM. PMID: 20856250.
      View in: PubMed   Mentions:
    84. DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics. Pharmgenomics Pers Med. 2010; 3:61-78. Turic D, Swanson J, Sonuga-Barke E. PMID: 23226043.
      View in: PubMed   Mentions:
    85. Parent-reported homework problems in the MTA study: evidence for sustained improvement with behavioral treatment. J Clin Child Adolesc Psychol. 2010; 39(2):220-33. Langberg JM, Arnold LE, Flowers AM, Epstein JN, Altaye M, Hinshaw SP, Swanson JM, Kotkin R, Simpson S, Molina BS, Jensen PS, Abikoff H, Pelham WE, Vitiello B, Wells KC, Hechtman L. PMID: 20390813.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    86. Adverse reactions to methylphenidate treatment for attention-deficit/hyperactivity disorder: structure and associations with clinical characteristics and symptom control. J Child Adolesc Psychopharmacol. 2009 Dec; 19(6):683-90. Sonuga-Barke EJ, Coghill D, Wigal T, DeBacker M, Swanson J. PMID: 20035586.
      View in: PubMed   Mentions:
    87. Measuring methylphenidate response in attention-deficit/hyperactvity disorder: how are laboratory classroom-based measures related to parent ratings? J Child Adolesc Psychopharmacol. 2009 Dec; 19(6):691-8. Sonuga-Barke EJ, Coghill D, DeBacker M, Swanson J. PMID: 20035587.
      View in: PubMed   Mentions:
    88. Cognitive control of drug craving inhibits brain reward regions in cocaine abusers. Neuroimage. 2010 Feb 01; 49(3):2536-43. Volkow ND, Fowler JS, Wang GJ, Telang F, Logan J, Jayne M, Ma Y, Pradhan K, Wong C, Swanson JM. PMID: 19913102.
      View in: PubMed   Mentions:
    89. Dissociation between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats in baseline performance and methylphenidate response on measures of attention, impulsivity and hyperactivity in a Visual Stimulus Position Discrimination Task. Pharmacol Biochem Behav. 2010 Jan; 94(3):374-9. Thanos PK, Ivanov I, Robinson JK, Michaelides M, Wang GJ, Swanson JM, Newcorn JH, Volkow ND. PMID: 19818805.
      View in: PubMed   Mentions:
    90. DSM-V and the future diagnosis of attention-deficit/hyperactivity disorder. Curr Psychiatry Rep. 2009 Oct; 11(5):399-406. Swanson JM, Wigal T, Lakes K. PMID: 19785982.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    91. Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA. 2009 Sep 09; 302(10):1084-91. Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F, Fowler JS, Zhu W, Logan J, Ma Y, Pradhan K, Wong C, Swanson JM. PMID: 19738093.
      View in: PubMed   Mentions:
    92. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med. 2009 Sep; 27(5):358-68. Wadhwa PD, Buss C, Entringer S, Swanson JM. PMID: 19711246.
      View in: PubMed   Mentions: 196     Fields:    Translation:HumansAnimals
    93. Developmental origins of health and disease: environmental exposures. Semin Reprod Med. 2009 Sep; 27(5):391-402. Swanson JM, Entringer S, Buss C, Wadhwa PD. PMID: 19711249.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansPHPublic Health
    94. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry. 2009 May; 48(5):484-500. Molina BSG, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, Hechtman L, Abikoff HB, Elliott GR, Greenhill LL, Newcorn JH, Wells KC, Wigal T, Gibbons RD, Hur K, Houck PR. PMID: 19318991.
      View in: PubMed   Mentions: 293     Fields:    Translation:Humans
    95. Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry. 2009 May; 48(5):501-510. Pappadopulos E, Jensen PS, Chait AR, Arnold LE, Swanson JM, Greenhill LL, Hechtman L, Chuang S, Wells KC, Pelham W, Cooper T, Elliott G, Newcorn JH. PMID: 19307987.
      View in: PubMed   Mentions:
    96. Hyperstimulation of striatal D2 receptors with sleep deprivation: Implications for cognitive impairment. Neuroimage. 2009 May 01; 45(4):1232-40. Volkow ND, Tomasi D, Wang GJ, Telang F, Fowler JS, Wang RL, Logan J, Wong C, Jayne M, Swanson JM. PMID: 19349237.
      View in: PubMed   Mentions:
    97. Psychopharmacology: concepts and opinions about the use of stimulant medications. J Child Psychol Psychiatry. 2009 Jan; 50(1-2):180-93. Swanson JM, Volkow ND. PMID: 19220601.
      View in: PubMed   Mentions:
    98. Psychometric properties of teacher SKAMP ratings from a community sample. Assessment. 2009 Jun; 16(2):193-208. Murray DW, Bussing R, Fernandez M, Garvan CW, Swanson JM, Eyberg SM. PMID: 19116413.
      View in: PubMed   Mentions:
    99. Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, Version IV Scale-Teacher Form. J Pediatr Psychol. 2009 Sep; 34(8):850-61. Gau SS, Lin CH, Hu FC, Shang CY, Swanson JM, Liu YC, Liu SK. PMID: 19074488.
      View in: PubMed   Mentions:
    100. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details. J Atten Disord. 2008 Jul; 12(1):15-43. Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B, Wigal T. PMID: 18573924.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    101. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. J Atten Disord. 2008 Jul; 12(1):4-14. Swanson J, Arnold LE, Kraemer H, Hechtman L, Molina B, Hinshaw S, Vitiello B, Jensen P, Steinhoff K, Lerner M, Greenhill L, Abikoff H, Wells K, Epstein J, Elliott G, Newcorn J, Hoza B, Wigal T. PMID: 18573923.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    102. Heterogeneity in the pharmacodynamics of two long-acting methylphenidate formulations for children with attention deficit/hyperactivity disorder. A growth mixture modelling analysis. Eur Child Adolesc Psychiatry. 2008 Jun; 17(4):245-54. Sonuga-Barke EJ, Van Lier P, Swanson JM, Coghill D, Wigal S, Vandenberghe M, Hatch S. PMID: 18071840.
      View in: PubMed   Mentions:
    103. Increasing use of stimulants warns of potential abuse. Nature. 2008 May 29; 453(7195):586. Swanson JM, Volkow ND. PMID: 18509418.
      View in: PubMed   Mentions:
    104. Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood? Am J Psychiatry. 2008 May; 165(5):553-5. Volkow ND, Swanson JM. PMID: 18450933.
      View in: PubMed   Mentions:
    105. Methylphenidate decreased the amount of glucose needed by the brain to perform a cognitive task. PLoS One. 2008 Apr 16; 3(4):e2017. Volkow ND, Fowler JS, Wang GJ, Telang F, Logan J, Wong C, Ma J, Pradhan K, Benveniste H, Swanson JM. PMID: 18414677.
      View in: PubMed   Mentions:
    106. Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: psychometric properties and normative ratings from a school district sample. Assessment. 2008 Sep; 15(3):317-28. Bussing R, Fernandez M, Harwood M, Garvan CW, Eyberg SM, Swanson JM. PMID: 18310593.
      View in: PubMed   Mentions:
    107. The action of enhancers can lead to addiction. Nature. 2008 Jan 31; 451(7178):520. Volkow ND, Swanson JM. PMID: 18235477.
      View in: PubMed   Mentions:
    108. Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, version IV scale - parent form. Int J Methods Psychiatr Res. 2008; 17(1):35-44. Gau SS, Shang CY, Liu SK, Lin CH, Swanson JM, Liu YC, Tu CL. PMID: 18286459.
      View in: PubMed   Mentions:
    109. Subtypes versus severity differences in attention-deficit/hyperactivity disorder in the Northern Finnish Birth Cohort. J Am Acad Child Adolesc Psychiatry. 2007 Dec; 46(12):1584-93. Lubke GH, Muthén B, Moilanen IK, McGough JJ, Loo SK, Swanson JM, Yang MH, Taanila A, Hurtig T, Järvelin MR, Smalley SL. PMID: 18030080.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    110. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol. 2007 Nov; 64(11):1575-9. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F. PMID: 17998440.
      View in: PubMed   Mentions:
    111. Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):581-92. Abikoff HB, Vitiello B, Riddle MA, Cunningham C, Greenhill LL, Swanson JM, Chuang SZ, Davies M, Kastelic E, Wigal SB, Evans L, Ghuman JK, Kollins SH, McCracken JT, McGough JJ, Murray DW, Posner K, Skrobala AM, Wigal T. PMID: 17979579.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    112. Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):621-34. Hardy KK, Kollins SH, Murray DW, Riddle MA, Greenhill L, Cunningham C, Abikoff HB, McCracken JT, Vitiello B, Davies M, McGough JJ, Posner K, Skrobala AM, Swanson JM, Wigal T, Wigal SB, Ghuman JK, Chuang SZ. PMID: 17979582.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    113. Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):593-604. Vitiello B, Abikoff HB, Chuang SZ, Kollins SH, McCracken JT, Riddle MA, Swanson JM, Wigal T, McGough JJ, Ghuman JK, Wigal SB, Skrobala AM, Davies M, Posner K, Cunningham C, Greenhill LL. PMID: 17979580.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    114. Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):635-46. Swanson JM, Moyzis RK, McGough JJ, McCracken JT, Riddle MA, Kollins SH, Greenhill LL, Abikoff HB, Wigal T, Wigal SB, Posner K, Skrobala AM, Davies M, Ghuman JK, Cunningham C, Vitiello B, Stehli A, Smalley SL, Grady D. PMID: 17979583.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    115. Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):563-80. Ghuman JK, Riddle MA, Vitiello B, Greenhill LL, Chuang SZ, Wigal SB, Kollins SH, Abikoff HB, McCracken JT, Kastelic E, Scharko AM, McGough JJ, Murray DW, Evans L, Swanson JM, Wigal T, Posner K, Cunningham C, Davies M, Skrobala AM. PMID: 17979578.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    116. Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):547-62. Posner K, Melvin GA, Murray DW, Gugga SS, Fisher P, Skrobala A, Cunningham C, Vitiello B, Abikoff HB, Ghuman JK, Kollins S, Wigal SB, Wigal T, McCracken JT, McGough JJ, Kastelic E, Boorady R, Davies M, Chuang SZ, Swanson JM, Riddle MA, Greenhill LL. PMID: 17979577.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    117. Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007 Oct; 17(5):605-20. Murray DW, Kollins SH, Hardy KK, Abikoff HB, Swanson JM, Cunningham C, Vitiello B, Riddle MA, Davies M, Greenhill LL, McCracken JT, McGough JJ, Posner K, Skrobala AM, Wigal T, Wigal SB, Ghuman JK, Chuang SZ. PMID: 17979581.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    118. Maternal depressive symptomatology and parenting behavior: exploration of possible mediators. J Abnorm Child Psychol. 2007 Oct; 35(5):705-14. Gerdes AC, Hoza B, Arnold LE, Pelham WE, Swanson JM, Wigal T, Jensen PS. PMID: 17674187.
      View in: PubMed   Mentions:
    119. Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry. 2007 Aug; 46(8):1028-1040. Molina BSG, Flory K, Hinshaw SP, Greiner AR, Arnold LE, Swanson JM, Hechtman L, Jensen PS, Vitiello B, Hoza B, Pelham WE, Elliott GR, Wells KC, Abikoff HB, Gibbons RD, Marcus S, Conners CK, Epstein JN, Greenhill LL, March JS, Newcorn JH, Severe JB, Wigal T. PMID: 17667481.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    120. 3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry. 2007 Aug; 46(8):989-1002. Jensen PS, Arnold LE, Swanson JM, Vitiello B, Abikoff HB, Greenhill LL, Hechtman L, Hinshaw SP, Pelham WE, Wells KC, Conners CK, Elliott GR, Epstein JN, Hoza B, March JS, Molina BSG, Newcorn JH, Severe JB, Wigal T, Gibbons RD, Hur K. PMID: 17667478.
      View in: PubMed   Mentions: 142     Fields:    Translation:HumansCTClinical Trials
    121. Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry. 2007 Aug; 46(8):1003-1014. Swanson JM, Hinshaw SP, Arnold LE, Gibbons RD, Marcus S, Hur K, Jensen PS, Vitiello B, Abikoff HB, Greenhill LL, Hechtman L, Pelham WE, Wells KC, Conners CK, March JS, Elliott GR, Epstein JN, Hoagwood K, Hoza B, Molina BSG, Newcorn JH, Severe JB, Wigal T. PMID: 17667479.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    122. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2007 Aug; 64(8):932-40. Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM. PMID: 17679638.
      View in: PubMed   Mentions:
    123. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry. 2007 Aug; 46(8):1015-1027. Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B, Hechtman L, Epstein JN, Pelham WE, Abikoff HB, Newcorn JH, Molina BSG, Hinshaw SP, Wells KC, Hoza B, Jensen PS, Gibbons RD, Hur K, Stehli A, Davies M, March JS, Conners CK, Caron M, Volkow ND. PMID: 17667480.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    124. Child and parent predictors of perceptions of parent--child relationship quality. J Atten Disord. 2007 Jul; 11(1):37-48. Gerdes AC, Hoza B, Arnold LE, Hinshaw SP, Wells KC, Hechtman L, Greenhill LL, Swanson JM, Pelham WE, Wigal T. PMID: 17606771.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    125. Sex differences in the response of children with ADHD to once-daily formulations of methylphenidate. J Am Acad Child Adolesc Psychiatry. 2007 Jun; 46(6):701-710. Sonuga-Barke EJS, Coghill D, Markowitz JS, Swanson JM, Vandenberghe M, Hatch SJ. PMID: 17513982.
      View in: PubMed   Mentions:
    126. A 30-year prospective follow-up study of hyperactive boys with conduct problems: adult criminality. J Am Acad Child Adolesc Psychiatry. 2007 May; 46(5):601-610. Satterfield JH, Faller KJ, Crinella FM, Schell AM, Swanson JM, Homer LD. PMID: 17450051.
      View in: PubMed   Mentions:
    127. Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2007 Apr; 17(2):153-64. Wigal SB, Gupta S, Greenhill L, Posner K, Lerner M, Steinhoff K, Wigal T, Kapelinski A, Martinez J, Modi NB, Stehli A, Swanson J. PMID: 17489710.
      View in: PubMed   Mentions:
    128. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev. 2007 Mar; 17(1):39-59. Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N, Taylor E, Casey BJ, Castellanos FX, Wadhwa PD. PMID: 17318414.
      View in: PubMed   Mentions: 155     Fields:    Translation:Humans
    129. Treatment for ADHD: is more complex treatment cost-effective for more complex cases? Health Serv Res. 2007 Feb; 42(1 Pt 1):165-82. Foster EM, Jensen PS, Schlander M, Pelham WE, Hechtman L, Arnold LE, Swanson JM, Wigal T. PMID: 17355587.
      View in: PubMed   Mentions:
    130. Brain dopamine transporter levels in treatment and drug naïve adults with ADHD. Neuroimage. 2007 Feb 01; 34(3):1182-90. Volkow ND, Wang GJ, Newcorn J, Fowler JS, Telang F, Solanto MV, Logan J, Wong C, Ma Y, Swanson JM, Schulz K, Pradhan K. PMID: 17126039.
      View in: PubMed   Mentions:
    131. Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry. 2006 Nov; 45(11):1294-1303. Wigal T, Greenhill L, Chuang S, McGOUGH J, Vitiello B, Skrobala A, Swanson J, Wigal S, Abikoff H, Kollins S, McCRACKEN J, Riddle M, Posner K, Ghuman J, Davies M, Thorp B, Stehli A. PMID: 17028508.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    132. Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry. 2006 Nov; 45(11):1304-1313. Swanson J, Greenhill L, Wigal T, Kollins S, Stehli A, Davies M, Chuang S, Vitiello B, Skrobala A, Posner K, Abikoff H, Oatis M, McCRACKEN J, McGOUGH J, Riddle M, Ghuman J, Cunningham C, Wigal S. PMID: 17023868.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    133. Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS). J Am Acad Child Adolesc Psychiatry. 2006 Nov; 45(11):1275-1283. Kollins S, Greenhill L, Swanson J, Wigal S, Abikoff H, McCRACKEN J, Riddle M, McGOUGH J, Vitiello B, Wigal T, Skrobala A, Posner K, Ghuman J, Davies M, Cunningham C, Bauzo A. PMID: 17023869.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    134. Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006 Nov; 45(11):1314-1322. McGOUGH J, McCRACKEN J, Swanson J, Riddle M, Kollins S, Greenhill L, Abikoff H, Davies M, Chuang S, Wigal T, Wigal S, Posner K, Skrobala A, Kastelic E, Ghuman J, Cunningham C, Shigawa S, Moyzis R, Vitiello B. PMID: 17023870.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    135. The National Children's Study: a 21-year prospective study of 100,000 American children. Pediatrics. 2006 Nov; 118(5):2173-86. Landrigan PJ, Trasande L, Thorpe LE, Gwynn C, Lioy PJ, D'Alton ME, Lipkind HS, Swanson J, Wadhwa PD, Clark EB, Rauh VA, Perera FP, Susser E. PMID: 17079592.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    136. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006 Nov; 45(11):1284-1293. Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, McGough J, Wigal S, Wigal T, Vitiello B, Skrobala A, Posner K, Ghuman J, Cunningham C, Davies M, Chuang S, Cooper T. PMID: 17023867.
      View in: PubMed   Mentions: 99     Fields:    Translation:Humans
    137. Functional connectivity of frontal cortex in healthy and ADHD children reflected in EEG coherence. Cereb Cortex. 2007 Aug; 17(8):1788-99. Murias M, Swanson JM, Srinivasan R. PMID: 17023555.
      View in: PubMed   Mentions:
    138. Reducing hyperactivity with a feedback actigraph: initial findings. Clin Child Psychol Psychiatry. 2006 Oct; 11(4):607-17. Tryon WW, Tryon GS, Kazlausky T, Gruen W, Swanson JM. PMID: 17163228.
      View in: PubMed   Mentions:
    139. A twin study of attention-deficit/hyperactivity disorder dimensions rated by the strengths and weaknesses of ADHD-symptoms and normal-behavior (SWAN) scale. Biol Psychiatry. 2007 Mar 01; 61(5):700-5. Hay DA, Bennett KS, Levy F, Sergeant J, Swanson J. PMID: 16962074.
      View in: PubMed   Mentions:
    140. Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol. 2006 Aug; 74(4):649-57. Wells KC, Chi TC, Hinshaw SP, Epstein JN, Pfiffner L, Nebel-Schwalm M, Owens EB, Arnold LE, Abikoff HB, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March J, Newcorn JH, Pelham WE, Severe JB, Swanson J, Vitiello B, Wigal T. PMID: 16881772.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    141. Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects. Neuroimage. 2006 Oct 01; 32(4):1782-92. Volkow ND, Wang GJ, Ma Y, Fowler JS, Wong C, Jayne M, Telang F, Swanson JM. PMID: 16757181.
      View in: PubMed   Mentions:
    142. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006 Jun; 45(6):642-657. Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, McCRACKEN JT, Swanson JM, Lopez M. PMID: 16721314.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    143. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. J Clin Psychiatry. 2006 May; 67(5):727-35. Biederman J, Swanson JM, Wigal SB, Boellner SW, Earl CQ, Lopez FA. PMID: 16841622.
      View in: PubMed   Mentions:
    144. A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006 May; 45(5):503-511. Greenhill LL, Biederman J, Boellner SW, Rugino TA, Sangal RB, Earl CQ, Jiang JG, Swanson JM. PMID: 16601402.
      View in: PubMed   Mentions:
    145. Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry. 2006 May; 47(5):446-56. Epstein JN, Conners CK, Hervey AS, Tonev ST, Arnold LE, Abikoff HB, Elliott G, Greenhill LL, Hechtman L, Hoagwood K, Hinshaw SP, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Wells K, Vitiello B, Wigal T. PMID: 16671928.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    146. Reaction time distribution analysis of neuropsychological performance in an ADHD sample. Child Neuropsychol. 2006 Apr; 12(2):125-40. Hervey AS, Epstein JN, Curry JF, Tonev S, Eugene Arnold L, Keith Conners C, Hinshaw SP, Swanson JM, Hechtman L. PMID: 16754533.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    147. Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government. J Am Acad Child Adolesc Psychiatry. 2006 Mar; 45(3):261-270. Deveaugh-Geiss J, March J, Shapiro M, Andreason PJ, Emslie G, Ford LM, Greenhill L, Murphy D, Prentice E, Roberts R, Silva S, Swanson JM, VAN Zwieten-Boot B, Vitiello B, Wagner KD, Mangum B. PMID: 16540810.
      View in: PubMed   Mentions:
    148. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. Can J Clin Pharmacol. 2006; 13(1):e50-62. Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE. PMID: 16456216.
      View in: PubMed   Mentions:
    149. Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies. Prim Care Companion J Clin Psychiatry. 2006; 8(6):352-60. Wigal SB, Biederman J, Swanson JM, Yang R, Greenhill LL. PMID: 17245457.
      View in: PubMed   Mentions:
    150. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J Clin Psychiatry. 2006 Jan; 67(1):137-47. Swanson JM, Greenhill LL, Lopez FA, Sedillo A, Earl CQ, Jiang JG, Biederman J. PMID: 16426100.
      View in: PubMed   Mentions:
    151. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics. 2005 Dec; 116(6):e777-84. Biederman J, Swanson JM, Wigal SB, Kratochvil CJ, Boellner SW, Earl CQ, Jiang J, Greenhill L. PMID: 16322134.
      View in: PubMed   Mentions:
    152. Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry. 2005 Sep; 162(9):1628-36. Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M, Hinshaw S, Vitiello B, Arnold LE, Elliott G, Hechtman L, Newcorn JH, Pelham WE, Swanson J, Wells K. PMID: 16135621.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    153. Long-acting stimulants: development and dosing. Can Child Adolesc Psychiatr Rev. 2005 Aug; 14(Supplement 1):4-9. Swanson JM. PMID: 19030518.
      View in: PubMed   Mentions:
    154. Using long-acting stimulants: does it change ADHD treatment outcome? Can Child Adolesc Psychiatr Rev. 2005 Aug; 14(Supplement 1):2-3. Swanson JM, Hechtman L. PMID: 19030517.
      View in: PubMed   Mentions:
    155. Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al. Cancer Lett. 2005 Dec 18; 230(2):292-4. Preston RJ, Kollins SH, Swanson JM, Greenhill LL, Wigal T, Elliott GR, Vitiello B. PMID: 16019134.
      View in: PubMed   Mentions:
    156. Sequence variants of the DRD4 gene in autism: further evidence that rare DRD4 7R haplotypes are ADHD specific. . 2005 Jul 05; 136B(1):33-5. Grady DL, Harxhi A, Smith M, Flodman P, Spence MA, Swanson JM, Moyzis RK. PMID: 15892149.
      View in: PubMed   Mentions:
    157. Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J Neurosci. 2005 Apr 13; 25(15):3932-9. Volkow ND, Wang GJ, Ma Y, Fowler JS, Wong C, Ding YS, Hitzemann R, Swanson JM, Kalivas P. PMID: 15829645.
      View in: PubMed   Mentions:
    158. Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol. 2005 Mar; 34(1):74-86. Hoza B, Gerdes AC, Mrug S, Hinshaw SP, Bukowski WM, Gold JA, Arnold LE, Abikoff HB, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Jensen PS, Kraemer HC, March JS, Newcorn JH, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T. PMID: 15677282.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    159. Dopamine receptor D4 (DRD4) gene in Han Chinese children with attention-deficit/hyperactivity disorder (ADHD): increased prevalence of the 2-repeat allele. . 2005 Feb 05; 133B(1):54-6. Leung PW, Lee CC, Hung SF, Ho TP, Tang CP, Kwong SL, Leung SY, Yuen ST, Lieh-Mak F, Oosterlaan J, Grady D, Harxhi A, Ding YC, Chi HC, Flodman P, Schuck S, Spence MA, Moyzis R, Swanson J. PMID: 15578612.
      View in: PubMed   Mentions:
    160. The services for children and adolescents-parent interview: development and performance characteristics. J Am Acad Child Adolesc Psychiatry. 2004 Nov; 43(11):1334-44. Jensen PS, Eaton Hoagwood K, Roper M, Arnold LE, Odbert C, Crowe M, Molina BS, Hechtman L, Hinshaw SP, Hoza B, Newcorn J, Swanson J, Wells K. PMID: 15502592.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    161. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2004 Nov; 43(11):1422-9. Quinn D, Wigal S, Swanson J, Hirsch S, Ottolini Y, Dariani M, Roffman M, Zeldis J, Cooper T. PMID: 15502602.
      View in: PubMed   Mentions:
    162. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2004 Nov; 43(11):1406-14. Wigal S, Swanson JM, Feifel D, Sangal RB, Elia J, Casat CD, Zeldis JB, Conners CK. PMID: 15502600.
      View in: PubMed   Mentions:
    163. Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data. BMC Psychiatry. 2004 Sep 30; 4:28. Sonuga-Barke EJ, Swanson JM, Coghill D, DeCory HH, Hatch SJ. PMID: 15458569.
      View in: PubMed   Mentions:
    164. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry. 2004 Jul; 161(7):1173-80. Volkow ND, Wang GJ, Fowler JS, Telang F, Maynard L, Logan J, Gatley SJ, Pappas N, Wong C, Vaska P, Zhu W, Swanson JM. PMID: 15229048.
      View in: PubMed   Mentions:
    165. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry. 2004 Jun; 9(6):557-69. Volkow ND, Fowler JS, Wang GJ, Swanson JM. PMID: 15098002.
      View in: PubMed   Mentions:
    166. Self-perceptions of competence in children with ADHD and comparison children. J Consult Clin Psychol. 2004 Jun; 72(3):382-91. Hoza B, Gerdes AC, Hinshaw SP, Arnold LE, Pelham WE, Molina BS, Abikoff HB, Epstein JN, Greenhill LL, Hechtman L, Odbert C, Swanson JM, Wigal T. PMID: 15279522.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    167. The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus. Am J Hum Genet. 2004 May; 74(5):931-44. Wang E, Ding YC, Flodman P, Kidd JR, Kidd KK, Grady DL, Ryder OA, Spence MA, Swanson JM, Moyzis RK. PMID: 15077199.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansCells
    168. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). Pediatrics. 2004 Mar; 113(3 Pt 1):e206-16. Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ. PMID: 14993578.
      View in: PubMed   Mentions:
    169. Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures. J Abnorm Child Psychol. 2004 Feb; 32(1):39-51. Arnold LE, Chuang S, Davies M, Abikoff HB, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, Langworthy-Lam KS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T. PMID: 14998110.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    170. Weekend holidays during methylphenidate use in ADHD children: a randomized clinical trial. J Child Adolesc Psychopharmacol. 2004; 14(2):195-206. Martins S, Tramontina S, Polanczyk G, Eizirik M, Swanson JM, Rohde LA. PMID: 15319017.
      View in: PubMed   Mentions:
    171. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci. 2003 Dec 10; 23(36):11461-8. Volkow ND, Wang GJ, Ma Y, Fowler JS, Zhu W, Maynard L, Telang F, Vaska P, Ding YS, Wong C, Swanson JM. PMID: 14673011.
      View in: PubMed   Mentions:
    172. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry. 2003 Nov; 160(11):1909-18. Volkow ND, Swanson JM. PMID: 14594733.
      View in: PubMed   Mentions:
    173. Serum and brain concentrations of methylphenidate: implications for use and abuse. Neurosci Biobehav Rev. 2003 Nov; 27(7):615-21. Swanson JM, Volkow ND. PMID: 14624806.
      View in: PubMed   Mentions:
    174. A pharmacokinetic/pharmacodynamic study comparing a single morning dose of adderall to twice-daily dosing in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2003 Oct; 42(10):1234-41. Greenhill LL, Swanson JM, Steinhoff K, Fried J, Posner K, Lerner M, Wigal S, Clausen SB, Zhang Y, Tulloch S. PMID: 14560174.
      View in: PubMed   Mentions:
    175. Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J Consult Clin Psychol. 2003 Aug; 71(4):713-27. Arnold LE, Elliot M, Sachs L, Bird H, Kraemer HC, Wells KC, Abikoff HB, Comarda A, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hindshaw SP, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wigal T. PMID: 12924677.
      View in: PubMed   Mentions:
    176. Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2003 Jun; 42(6):673-83. McCracken JT, Biederman J, Greenhill LL, Swanson JM, McGough JJ, Spencer TJ, Posner K, Wigal S, Pataki C, Zhang Y, Tulloch S. PMID: 12921475.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    177. Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall. J Am Acad Child Adolesc Psychiatry. 2003 Jun; 42(6):684-91. McGough JJ, Biederman J, Greenhill LL, McCracken JT, Spencer TJ, Posner K, Wigal S, Gornbein J, Tulloch S, Swanson JM. PMID: 12921476.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    178. Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol. 2003 Jun; 71(3):540-52. Owens EB, Hinshaw SP, Kraemer HC, Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott G, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T. PMID: 12795577.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    179. High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder. Mol Psychiatry. 2003 May; 8(5):536-45. Grady DL, Chi HC, Ding YC, Smith M, Wang E, Schuck S, Flodman P, Spence MA, Swanson JM, Moyzis RK. PMID: 12808433.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    180. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2003 Apr; 42(4):424-33. Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M. PMID: 12649629.
      View in: PubMed   Mentions:
    181. Catecholamine response to exercise in children with attention deficit hyperactivity disorder. Pediatr Res. 2003 May; 53(5):756-61. Wigal SB, Nemet D, Swanson JM, Regino R, Trampush J, Ziegler MG, Cooper DM. PMID: 12621106.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    182. Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma. Psychopharmacology (Berl). 2003 Mar; 166(3):264-70. Volkow ND, Wang GJ, Fowler JS, Molina PE, Logan J, Gatley SJ, Gifford A, Ding YS, Wong C, Pappas NR, Zhu W, Swanson JM. PMID: 12589522.
      View in: PubMed   Mentions:
    183. The effect of methylphenidate on three forms of response inhibition in boys with AD/HD. J Abnorm Child Psychol. 2003 Feb; 31(1):105-20. Scheres A, Oosterlaan J, Swanson J, Morein-Zamir S, Meiran N, Schut H, Vlasveld L, Sergeant JA. PMID: 12597703.
      View in: PubMed   Mentions:
    184. Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies. Arch Gen Psychiatry. 2003 Feb; 60(2):204-11. Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, Lindemulder E, Wigal S. PMID: 12578439.
      View in: PubMed   Mentions:
    185. Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement. CNS Drugs. 2003; 17(2):117-31. Swanson J. PMID: 12521359.
      View in: PubMed   Mentions:
    186. Role of executive function in ADHD. J Clin Psychiatry. 2003; 64 Suppl 14:35-9. Swanson JM. PMID: 14658934.
      View in: PubMed   Mentions:
    187. Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J Child Adolesc Psychopharmacol. 2003; 13(2):123-36. Galanter CA, Carlson GA, Jensen PS, Greenhill LL, Davies M, Li W, Chuang SZ, Elliott GR, Arnold LE, March JS, Hechtman L, Pelham WE, Swanson JM. PMID: 12880507.
      View in: PubMed   Mentions:
    188. Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD: effects on activity level in the classroom and on the playground. J Am Acad Child Adolesc Psychiatry. 2002 Nov; 41(11):1306-14. Swanson JM, Gupta S, Williams L, Agler D, Lerner M, Wigal S. PMID: 12410072.
      View in: PubMed   Mentions:
    189. Assessing the molecular genetics of attention networks. BMC Neurosci. 2002 Oct 04; 3:14. Fossella J, Sommer T, Fan J, Wu Y, Swanson JM, Pfaff DW, Posner MI. PMID: 12366871.
      View in: PubMed   Mentions:
    190. Observed classroom behavior of children with ADHD: relationship to gender and comorbidity. J Abnorm Child Psychol. 2002 Aug; 30(4):349-59. Abikoff HB, Jensen PS, Arnold LL, Hoza B, Hechtman L, Pollack S, Martin D, Alvir J, March JS, Hinshaw S, Vitiello B, Newcorn J, Greiner A, Cantwell DP, Conners CK, Elliott G, Greenhill LL, Kraemer H, Pelham WE, Severe JB, Swanson JM, Wells K, Wigal T. PMID: 12109488.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    191. Response to commentary on the multimodal treatment study of ADHD (MTA): mining the meaning of the MTA. J Abnorm Child Psychol. 2002 Aug; 30(4):327-32. Swanson JM, Arnold LE, Vitiello B, Abikoff HB, Wells KC, Pelham WE, March JS, Hinshaw SP, Hoza B, Epstein JN, Elliott GR, Greenhill LL, Hechtman L, Jensen PS, Kraemer HC, Kotkin R, Molina B, Newcorn JH, Owens EB, Severe J, Hoagwood K, Simpson S, Wigal T, Hanley T. PMID: 12108764.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    192. Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution. J Am Acad Child Adolesc Psychiatry. 2002 May; 41(5):498-504. Abikoff H, Arnold LE, Newcorn JH, Elliott GR, Hechtman L, Severe JB, Wigal T, Shapiro C, Cantwell DP, Conners CK, Greenhill LL, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Pelham WE, Swanson JM, Vitiello B, Wells KC. PMID: 12014781.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    193. Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD. Behav Brain Res. 2002 Mar 10; 130(1-2):73-8. Swanson JM, Volkow ND. PMID: 11864720.
      View in: PubMed   Mentions:
    194. Socioeconomic status as a moderator of ADHD treatment outcomes. J Am Acad Child Adolesc Psychiatry. 2002 Mar; 41(3):269-77. Rieppi R, Greenhill LL, Ford RE, Chuang S, Wu M, Davies M, Abikoff HB, Arnold LE, Conners CK, Elliott GR, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T. PMID: 11886021.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    195. A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics. 2002 Mar; 109(3):E39. Greenhill LL, Findling RL, Swanson JM. PMID: 11875167.
      View in: PubMed   Mentions:
    196. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse. 2002 Mar 01; 43(3):181-7. Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford A, Zhu W, Swanson JM. PMID: 11793423.
      View in: PubMed   Mentions:
    197. Attentional phenotypes for the analysis of higher mental function. ScientificWorldJournal. 2002 Jan 24; 2:217-23. Fossella J, Posner MI, Fan J, Swanson JM, Pfaff DW. PMID: 12806053.
      View in: PubMed   Mentions:
    198. The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications. J Atten Disord. 2002; 6 Suppl 1:S73-88. Swanson JM, Lerner M, Wigal T, Steinhoff K, Greenhill L, Posner K, Freid J, Wigal S. PMID: 12685522.
      View in: PubMed   Mentions:
    199. Guidelines and algorithms for the use of methylphenidate in children with Attention-Deficit/ Hyperactivity Disorder. J Atten Disord. 2002; 6 Suppl 1:S89-100. Greenhill L, Beyer DH, Finkleson J, Shaffer D, Biederman J, Conners CK, Gillberg C, Huss M, Jensen P, Kennedy JL, Klein R, Rapoport J, Sagvolden T, Spencer T, Swanson JM, Volkow N. PMID: 12685523.
      View in: PubMed   Mentions:
    200. Evidence of positive selection acting at the human dopamine receptor D4 gene locus. Proc Natl Acad Sci U S A. 2002 Jan 08; 99(1):309-14. Ding YC, Chi HC, Grady DL, Morishima A, Kidd JR, Kidd KK, Flodman P, Spence MA, Schuck S, Swanson JM, Zhang YP, Moyzis RK. PMID: 11756666.
      View in: PubMed   Mentions: 120     Fields:    Translation:HumansCells
    201. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001 Feb; 40(2):168-79. Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB, Clevenger W, Davies M, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Owens EB, Pelham WE, Schiller E, Severe JB, Simpson S, Vitiello B, Wells K, Wigal T, Wu M. PMID: 11211365.
      View in: PubMed   Mentions: 234     Fields:    Translation:Humans
    202. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001 Feb; 40(2):147-58. Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, March JS, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Pelham WE, Severe JB, Swanson JM, Wells KC, Wigal T, Vitiello B. PMID: 11211363.
      View in: PubMed   Mentions: 174     Fields:    Translation:Humans
    203. Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry. 2001 Feb; 40(2):159-67. Conners CK, Epstein JN, March JS, Angold A, Wells KC, Klaric J, Swanson JM, Arnold LE, Abikoff HB, Elliott GR, Greenhill LL, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, Newcorn JH, Pelham WE, Severe JB, Vitiello B, Wigal T. PMID: 11211364.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    204. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry. 2001 Feb; 40(2):180-7. Greenhill LL, Swanson JM, Vitiello B, Davies M, Clevenger W, Wu M, Arnold LE, Abikoff HB, Bukstein OG, Conners CK, Elliott GR, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Severe JB, Wells K, Wigal T. PMID: 11211366.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCTClinical Trials
    205. Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. J Am Acad Child Adolesc Psychiatry. 2001 Feb; 40(2):188-96. Vitiello B, Severe JB, Greenhill LL, Arnold LE, Abikoff HB, Bukstein OG, Elliott GR, Hechtman L, Jensen PS, Hinshaw SP, March JS, Newcorn JH, Swanson JM, Cantwell DP. PMID: 11211367.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    206. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr. 2001 Feb; 22(1):60-73. Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE, Abikoff HB, Elliott G, Hechtman L, Hoza B, March JS, Newcorn JH, Severe JB, Vitiello B, Wells K, Wigal T. PMID: 11265923.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansCTClinical Trials
    207. Symptom profiles in children with ADHD: effects of comorbidity and gender. J Am Acad Child Adolesc Psychiatry. 2001 Feb; 40(2):137-46. Newcorn JH, Halperin JM, Jensen PS, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Epstein JN, Greenhill LL, Hechtman L, Hinshaw SP, Hoza B, Kraemer HC, Pelham WE, Severe JB, Swanson JM, Wells KC, Wigal T, Vitiello B. PMID: 11214601.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    208. Linkage of the dopamine D4 receptor gene and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2000 Dec; 39(12):1537-42. Sunohara GA, Roberts W, Malone M, Schachar RJ, Tannock R, Basile VS, Wigal T, Wigal SB, Schuck S, Moriarty J, Swanson JM, Kennedy JL, Barr CL. PMID: 11128331.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    209. Familial aggregation of ADHD characteristics. J Abnorm Child Psychol. 2000 Dec; 28(6):585-94. Epstein JN, Conners CK, Erhardt D, Arnold LE, Hechtman L, Hinshaw SP, Hoza B, Newcorn JH, Swanson JM, Vitiello B. PMID: 11104319.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    210. Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation. J Abnorm Child Psychol. 2000 Dec; 28(6):483-505. Wells KC, Pelham WE, Kotkin RA, Hoza B, Abikoff HB, Abramowitz A, Arnold LE, Cantwell DP, Conners CK, Del Carmen R, Elliott G, Greenhill LL, Hechtman L, Hibbs E, Hinshaw SP, Jensen PS, March JS, Swanson JM, Schiller E. PMID: 11104313.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    211. Parent cognitions as predictors of child treatment response in attention-deficit/hyperactivity disorder. J Abnorm Child Psychol. 2000 Dec; 28(6):569-83. Hoza B, Owens JS, Pelham WE, Swanson JM, Conners CK, Hinshaw SP, Arnold LE, Kraemer HC. PMID: 11104318.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    212. Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol. 2000 Dec; 28(6):555-68. Hinshaw SP, Owens EB, Wells KC, Kraemer HC, Abikoff HB, Arnold LE, Conners CK, Elliott G, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Swanson JM, Vitiello B, Wigal T. PMID: 11104317.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCTClinical Trials
    213. Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). J Abnorm Child Psychol. 2000 Dec; 28(6):527-41. March JS, Swanson JM, Arnold LE, Hoza B, Conners CK, Hinshaw SP, Hechtman L, Kraemer HC, Greenhill LL, Abikoff HB, Elliott LG, Jensen PS, Newcorn JH, Vitiello B, Severe J, Wells KC, Pelham WE. PMID: 11104315.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    214. Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. J Abnorm Child Psychol. 2000 Dec; 28(6):507-25. Pelham WE, Gnagy EM, Greiner AR, Hoza B, Hinshaw SP, Swanson JM, Simpson S, Shapiro C, Bukstein O, Baron-Myak C, McBurnett K. PMID: 11104314.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    215. Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study. J Abnorm Child Psychol. 2000 Dec; 28(6):543-53. Wells KC, Epstein JN, Hinshaw SP, Conners CK, Klaric J, Abikoff HB, Abramowitz A, Arnold LE, Elliott G, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Pelham W, Pfiffner L, Severe J, Swanson JM, Vitiello B, Wigal T. PMID: 11104316.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    216. Attention deficit/hyperactivity disorder: characteristics, interventions and models. Neurotoxicol Teratol. 2000 Sep-Oct; 22(5):631-51. Paule MG, Rowland AS, Ferguson SA, Chelonis JJ, Tannock R, Swanson JM, Castellanos FX. PMID: 11106857.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    217. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2000 Jul; 39(7):908-19. Pliszka SR, Greenhill LL, Crismon ML, Sedillo A, Carlson C, Conners CK, McCracken JT, Swanson JM, Hughes CW, Llana ME, Lopez M, Toprac MG. PMID: 10892234.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    218. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II: Tactics. Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2000 Jul; 39(7):920-7. Pliszka SR, Greenhill LL, Crismon ML, Sedillo A, Carlson C, Conners CK, McCracken JT, Swanson JM, Hughes CW, Llana ME, Lopez M, Toprac MG. PMID: 10892235.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    219. Dopamine-transporter density in patients with ADHD. Lancet. 2000 Apr 22; 355(9213):1461; author reply 1461-2. Swanson JM. PMID: 10791548.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    220. Carbamazepine reduces dopamine-mediated behavior in chronic neuroleptic-treated and untreated rats: implications for treatment of tardive dyskinesia and hyperdopaminergic states. Exp Clin Psychopharmacol. 2000 Feb; 8(1):125-132. LaHoste GJ, Wigal T, King BH, Schuck SEB, Crinella FM, Swanson JM. PMID: 10743913.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    221. Dopamine genes and ADHD. Neurosci Biobehav Rev. 2000 Jan; 24(1):21-5. Swanson JM, Flodman P, Kennedy J, Spence MA, Moyzis R, Schuck S, Murias M, Moriarity J, Barr C, Smith M, Posner M. PMID: 10654656.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCTClinical Trials
    222. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999 Dec; 38(12):1551-9. Connor DF, Fletcher KE, Swanson JM. PMID: 10596256.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCTClinical Trials
    223. Anxiolytics, adrenergic agents, and naltrexone. J Am Acad Child Adolesc Psychiatry. 1999 May; 38(5):546-56. Riddle MA, Bernstein GA, Cook EH, Leonard HL, March JS, Swanson JM. PMID: 10230186.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    224. Combining methylphenidate and clonidine: a clinically sound medication option. J Am Acad Child Adolesc Psychiatry. 1999 May; 38(5):614-9; discussion 619-22. Wilens TE, Spencer TJ, Swanson JM, Connor DF, Cantwell D. PMID: 10230195.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    225. Analog classroom assessment of Adderall in children with ADHD. J Am Acad Child Adolesc Psychiatry. 1998 May; 37(5):519-26. Swanson JM, Wigal S, Greenhill LL, Browne R, Waslik B, Lerner M, Williams L, Flynn D, Agler D, Crowley K, Fineberg E, Baren M, Cantwell DP. PMID: 9585654.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    226. Effect of reinforcement on facial responsivity and persistence in children with attention-deficit hyperactivity disorder. Behav Modif. 1998 Apr; 22(2):143-66. Wigal T, Swanson JM, Douglas VI, Wigal SB, Wippler CM, Cavoto KF. PMID: 9563288.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    227. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet. 1998 Feb 07; 351(9100):429-33. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barke EJ, Jensen PS, Cantwell DP. PMID: 9482319.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    228. Evaluation of individual subjects in the analog classroom setting: I. Examples of graphical and statistical procedures for within-subject ranking of responses to different delivery patterns of methylphenidate. Psychopharmacol Bull. 1998; 34(4):825-32. Swanson JM, Wigal SB, Udrea D, Lerner M, Agler D, Flynn D, Fineberg E, Davies M, Kardatzke D, Ram A, Gupta S. PMID: 10513459.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    229. Reliability and validity of the SKAMP rating scale in a laboratory school setting. Psychopharmacol Bull. 1998; 34(1):47-53. Wigal SB, Gupta S, Guinta D, Swanson JM. PMID: 9564198.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    230. Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Mol Psychiatry. 1998 Jan; 3(1):38-41. Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg E, Wigal T, Lerner M, Williams L, LaHoste GJ, Wigal S. PMID: 9491811.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    231. Evaluation of individual subjects in the analog classroom setting: II. Effects of dose of amphetamine (Adderall). Psychopharmacol Bull. 1998; 34(4):833-8. Wigal SB, Swanson JM, Greenhill L, Waslick B, Cantwell D, Clevenger W, Davies M, Lerner M, Regino R, Fineberg E, Baren M, Browne R. PMID: 10513460.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    232. Lateralized attentional deficits in drug-free and medicated schizophrenic patients. Neuropsychologia. 1997 Dec; 35(12):1519-25. Wigal SB, Swanson JM, Potkin SG. PMID: 9460721.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    233. Asymmetrical hemispheric control of visual-spatial attention in adults with attention deficit hyperactivity disorder. Neuropsychology. 1997 Oct; 11(4):467-473. Epstein JN, Conners CK, Erhardt D, March JS, Swanson JM. PMID: 9345690.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    234. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry. 1997 Sep; 54(9):865-70. Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott G, Greenhill LL, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Pelham WE, Richters JE, Schiller E, Severe JB, Swanson JM, Vereen D, Wells KC. PMID: 9294378.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCTClinical Trials
    235. Covert visual spatial attention in boys with attention deficit hyperactivity disorder: lateral effects, methylphenidate response and results for parents. Neuropsychologia. 1997 Feb; 35(2):165-76. Nigg JT, Swanson JM, Hinshaw SP. PMID: 9025120.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    236. Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry. 1996 Oct; 35(10):1304-13. Greenhill LL, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott G, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, March JS, Newcorn J, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells K. PMID: 8885584.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCTClinical Trials
    237. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry. 1996 May; 1(2):121-4. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL. PMID: 9118321.
      View in: PubMed   Mentions: 113     Fields:    Translation:Humans
    238. Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures. J Am Acad Child Adolesc Psychiatry. 1995 Nov; 34(11):1504-13. Pelham WE, Swanson JM, Furman MB, Schwindt H. PMID: 8543519.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    239. More frequent diagnosis of attention deficit-hyperactivity disorder. N Engl J Med. 1995 Oct 05; 333(14):944. Swanson JM, Lerner M, Williams L. PMID: 7666894.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    240. NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. J Am Acad Child Adolesc Psychiatry. 1995 Aug; 34(8):987-1000. Richters JE, Arnold LE, Jensen PS, Abikoff H, Conners CK, Greenhill LL, Hechtman L, Hinshaw SP, Pelham WE, Swanson JM. PMID: 7665456.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    241. Hemispheric processing and methylphenidate effects in attention-deficit hyperactivity disorder. J Child Neurol. 1994 Apr; 9(2):181-9. Malone MA, Kershner JR, Swanson JM. PMID: 8006372.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    242. Effects of methylphenidate on impulsive responding in children with attention-deficit hyperactivity disorder. J Child Neurol. 1993 Apr; 8(2):157-63. Malone MA, Swanson JM. PMID: 8505479.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    243. The impact of an intensive multisensory reading program on a population of learning-disabled delinquents. Ann Dyslexia. 1992 Dec; 42(1):54-66. Simpson SB, Swanson JM, Kunkel K. PMID: 24233868.
      View in: PubMed   Mentions:
    244. Stimulant medication and reading performance: follow-up on sustained dose in ADHD boys with and without conduct disorders. J Learn Disabil. 1992 Feb; 25(2):115-23. Forness SR, Swanson JM, Cantwell DP, Youpa D, Hanna GL. PMID: 1583417.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    245. Auditory attention switching in hyperactive children. J Abnorm Child Psychol. 1991 Aug; 19(4):479-92. Pearson DA, Lane DM, Swanson JM. PMID: 1757713.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    246. Differential effects of stimulant medication on reading performance of boys with hyperactivity with and without conduct disorder. J Learn Disabil. 1991 May; 24(5):304-10. Forness SR, Cantwell DP, Swanson JM, Hanna GL, Youpa D. PMID: 2045727.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    247. Effects of stimulant medication on learning in children with ADHD. J Learn Disabil. 1991 Apr; 24(4):219-30, 255. Swanson JM, Cantwell D, Lerner M, McBurnett K, Hanna G. PMID: 1875157.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    248. A divided attention analysis of the effects of methylphenidate on the arithmetic performance of children with attention-deficit hyperactivity disorder. J Child Psychol Psychiatry. 1991 Mar; 32(3):463-71. Carlson CL, Pelham WE, Swanson JM, Wagner JL. PMID: 2061366.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    249. Activating tasks for the study of visual-spatial attention in ADHD children: a cognitive anatomic approach. J Child Neurol. 1991; 6 Suppl:S119-27. Swanson JM, Posner M, Potkin S, Bonforte S, Youpa D, Fiore C, Cantwell D, Crinella F. PMID: 2002210.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    250. Family factors associated with aggressive symptomatology in boys with attention deficit hyperactivity disorder: a research note. J Child Psychol Psychiatry. 1990 May; 31(4):629-36. Marshall VG, Longwell L, Goldstein MJ, Swanson JM. PMID: 2365764.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    251. Genetic latent structure analysis of dysmorphology in attention deficit disorder. J Am Acad Child Adolesc Psychiatry. 1990 Mar; 29(2):189-94. Deutsch CK, Matthysse S, Swanson JM, Farkas LG. PMID: 2324060.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    252. Self-paced learning in children with attention deficit disorder with hyperactivity. J Abnorm Child Psychol. 1989 Jun; 17(3):269-75. Dalby JT, Kinsbourne M, Swanson JM. PMID: 2666475.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    253. Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder. J Am Acad Child Adolesc Psychiatry. 1988 Mar; 27(2):171-4. Bowden CL, Deutsch CK, Swanson JM. PMID: 3360718.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    254. Natural social behaviors in hyperactive children: dose effects of methylphenidate. J Consult Clin Psychol. 1987 Apr; 55(2):187-93. Whalen CK, Henker B, Swanson JM, Granger D, Kliewer W, Spencer J. PMID: 3571671.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    255. Blood levels and tolerance to stimulants in ADDH children. Clin Neuropharmacol. 1986; 9 Suppl 4:523-5. Swanson JM, Lerner M, Cantwell D. PMID: 3567959.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    256. Pemoline pharmacokinetics and long term therapy in children with attention deficit disorder and hyperactivity. Clin Pharmacokinet. 1985 May-Jun; 10(3):269-78. Collier CP, Soldin SJ, Swanson JM, MacLeod SM, Weinberg F, Rochefort JG. PMID: 4017397.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    257. Methylphenidate hydrochloride given with or before breakfast: I. Behavioral, cognitive, and electrophysiologic effects. Pediatrics. 1983 Jul; 72(1):49-55. Swanson JM, Sandman CA, Deutsch C, Baren M. PMID: 6866591.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    258. Methylphenidate hydrochloride given with or before breakfast: II. Effects on plasma concentration of methylphenidate and ritalinic acid. Pediatrics. 1983 Jul; 72(1):56-9. Chan YP, Swanson JM, Soldin SS, Thiessen JJ, Macleod SM, Logan W. PMID: 6866592.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    259. Methylphenidate increases selectivity of visual scanning in children referred for hyperactivity. J Abnorm Child Psychol. 1982 Jun; 10(2):145-61. Flintoff MM, Barron RW, Swanson JM, Ledlow A, Kinsbourne M. PMID: 7108059.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    260. Overrepresentation of adoptees in children with the attention deficit disorder. Behav Genet. 1982 Mar; 12(2):231-8. Deutsch CK, Swanson JM, Bruell JH, Cantwell DP, Weinberg F, Baren M. PMID: 7126106.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    261. Food dyes and impairment of performance in hyperactive children. Science. 1981 Jan 23; 211(4480):411. Swanson JM, Kinsbourne M. PMID: 17748275.
      View in: PubMed   Mentions:
    262. Food dyes impair performance of hyperactive children on a laboratory learning test. Science. 1980 Mar 28; 207(4438):1485-7. Swanson JM, Kinsbourne M. PMID: 7361102.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    263. Auditory attention in hyperactive children: effects of stimulant medication on dichotic listening performance. J Abnorm Psychol. 1979 Feb; 88(1):27-32. Hiscock M, Kinsbourne M, Caplan B, Swanson JM. PMID: 422801.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    264. Reaction times and evoked potentials as indicators of hemispheric differences for laterally presented name and physical matches. J Exp Psychol Hum Percept Perform. 1978 Aug; 4(3):440-54. Ledlow A, Swanson JM, Kinsbourne M. PMID: 681891.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    265. Differences in reaction times and average evoked potentials as a function of direct and indirect neural pathways. Ann Neurol. 1978 Jun; 3(6):525-30. Ledlow A, Swanson JM, Kinsbourne M. PMID: 677817.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    266. An examination of the double-blind design in drug research with hyperactive children. Prog Neuropsychopharmacol. 1978; 2(1):123-7. Dalby JT, Kapelus GJ, Swanson JM, Kinsbourne M, Roberts W. PMID: 364511.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    267. Hyperactive children's underuse of learning time: correction by stimulant treatment. Child Dev. 1977 Dec; 48(4):1448-53. Dalby JT, Kinsbourne M, Swanson JM, Sobol MP. PMID: 608366.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    268. Measuring interhemispheric transfer time in man. Trans Am Neurol Assoc. 1977; 102:163-7. Kinsbourne M, Swanson JM, Ledlow A. PMID: 210552.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    269. Stimulant-related state-dependent learning in hyperactive children. Science. 1976 Jun 25; 192(4246):1354-7. Swanson JM, Kinsbourne M. PMID: 1273596.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials